X Corp. CEO Linda Yaccarino told CNBC that she has "autonomy" under Elon Musk, adding that she wants advertisers to be comfortable to return.
Share:
More In Business
Don’t Miss Out! Essential Tips for Amazon Prime Day (Week)
Retail expert Trae Bodge shares top Prime Day tips, the best deals to grab, and smart shopping strategies to save big—during and beyond the event.
Meta's Superintelligence Labs Unveiled: Analyzing the Tech Giant's Next Bold Move
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO Group Charts a Bold Course Toward the Future of Aerospace and Urban Air Mobility
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
What to Expect This Summer: Tariffs, Jobs, and Interest Rates
Rob Sockin, Senior Global Economist at Citi, joins J.D. Durkin to discuss tariffs, Q1 review, jobs data, and Fed rate cut expectations.
Swift Strategy: Ten Power Moves from Taylor Every Business (and Person) Can Learn From
Sinéad O’Sullivan explores ten strategic lessons from Taylor Swift’s empire in her new book Good Ideas and Power Moves—dropping September 9, 2025.
Big Business This Week: In the crypto casino, the house always wins
NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.
U.S. Private Payrolls Fall by 33K in June, Shaking Labor Market Optimism
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
Peach & Lily CEO On Going From K‑Beauty Pioneer to 2025’s Skincare Brand of the Year
Alicia Yoon, CEO of Peach & Lily, explores K‑Beauty’s rise, their plant‑powered innovation process & the popularity of the glass skin trend. Watch!
Pharma Stocks Soar Amid Medicaid Cuts and Trump’s Price Pressure — Here’s Why
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
